Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Value Group Brings Its Integrated Global IROPS Management Model to the World Aviation Festival
-
U.S. FDA Accepts Bayer’s Supplemental New Drug Application for KERENDIA® (finerenone) to Treat Adults with Chronic Kidney Disease (CKD) Without Diabetes
-
Markel International launches new chemical, oil & gas related energy property offering for small to midsize US-domiciled businesses
-
Gensight Biologics and the 15-20 National Hospital Announce NEJM Publication on GS030 Phase 1/2 Trial Results in Late-Stage Retinitis Pigmentosa
-
LEADING EDGE MATERIALS SIGNS MoU WITH TRILLIUN FOR NORRA KÄRR NEPHELINE SYENITE AND AEGIRINE CO-PRODUCTS
-
The decision of the management company of INVL Technology on the purchase of own shares
-
LEADING EDGE MATERIALS SIGNS MoU WITH TRILLIUN FOR NORRA KÄRR NEPHELINE SYENITE AND AEGIRINE CO-PRODUCTS
-
Michelin: Disclosure of trading in own shares - October 8th, 2026
-
Mephexus Group's Luce di Monti Introduces Lifetime Guarantee on Every ZEVERRA™ Stone It Sets
-
Mephexus Group's Luce di Monti Introduces Lifetime Guarantee on Every ZEVERRA™ Stone It Sets
-
Socfin publishes its 2026-2031 Sustainability Strategy and updated Responsible Management Policy
-
Argus launches alternative European ethylene and propylene price indexes
-
Tether News: $2.76M Frozen-Wallet Lawsuit Erupts as Remittix Tests Stablecoin Payment Rails
-
Recover™ Launches Recover™One, A 100% Recycled Fiber Blend Range That Eliminates Downstream Overdyeing
-
FORVIA HELLA receives major series orders for highly integrated EnergyCore solutions
-
Getlink SE: Shuttle Traffic in September 2026
-
High Levels of Trust Elevate the Fortune 100 Best Companies to Work For, Europe in 2026
-
Notice to attend Extraordinary General Meeting in INQ Group AB (publ)
-
NBPE Announces Transaction in Own Shares
-
Transaction in Own Shares
-
AB Tewox completes the construction of a EUR 6 million grocery store in Vilnius
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 08
-
Ethereum Price Prediction: Can ETH Rebound After a $202M ETF Outflow Before Remittix Goes Live?
-
Bitcoin ETF Giant IBIT Reaches $67B as Remittix Targets the Next Generation of Crypto Buyers
-
INQ substantially deleverages its balance sheet as secured lenders convert USD 5.4 million of convertible debt into shares
-
Bavarian Nordic Upgrades Full-Year 2026 Financial Guidance After Strong Travel Health Performance
-
Avatar Medical Receives CE Marking for Avatar Medical Vision, the First Software CE-Marked for Use with a Glasses-Free 3D Medical Display
-
Date of virtual 2026 Annual Meeting of Stockholders Announced by Reading International, Inc.
-
Colruyt Group Crosses the 150 Store Milestone With Rollout of Toshiba ELERA® Self Service Store Deployments
-
Best's Market Segment Report: Sub-Saharan Africa’s Reinsurers Maintain Robust Performance Amid Moderating Market Conditions
-
SWIM Women’s Entrepreneur Success Club: From Credit to Capital launches purpose-before-product education for women entrepreneurs
-
XRP Price Prediction: Can Evernorth’s Nasdaq Arrival Push XRP Toward $3 Before RTX Launch?
-
BNB Price Prediction: $850 Won’t Recreate ICO Fortunes as AlphaPepe Offers an Exchange Token Before Its First Listing
-
Marketing Maven's Shayne Wells Named a Greater Conejo Valley Chamber of Commerce 2026 40 Under Forty Honoree
-
Axelera AI Appoints Osman Kent and Catherine Lewis La Torre CBE as Non-Executive Directors
-
GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders
-
Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older
-
Affordable Dental Implants: A Professional Guide to Quality Care
-
LG ELECTRONICS BRINGS INTEGRATED NEXT-GENERATION VEHICLE SOLUTIONS TO GENESIS GV90
-
24X National Exchange Plans to Expand Warrant Performance Incentive Program
-
argenx Provides Update on Phase 3 UNITY Study of Efgartigimod SC in Sjögren's Disease
-
argenx Provides Update on Phase 3 UNITY Study of Efgartigimod SC in Sjögren's Disease
-
Start of Day Message
-
argenx Announces Positive Topline Results from Phase 2 Study of FB102 in Celiac Disease
-
TGS Q3 2026 Operational Update
-
Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia
-
Regulated information – inside information: Fagron delivers strong 23.2% revenue growth in the third quarter to €281.3 million and confirms FY guidance range
-
Erika Slayton: Veteran Mortgage Advisor Earns Top Honors
-
ROB FITZPATRICK BECOMES TWO-TIME AMAZON #1 AUTHOR WITH THE MILLIONAIRE MAKER
-
JBL High Performance Announces “The Room” to Address Leadership Isolation Among Senior Executives
